Phenylethylamine-oxidizing defect in migraine: circulatory implications.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001794:Blood Pressure; D002560:Cerebrovascular Circulation; D004032:Diet; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008881:Migraine Disorders / Q000201:enzymology / Q000378:metabolism* / Q000503:physiopathology; D008995:Monoamine Oxidase / Q000378:metabolism; D010084:Oxidation-Reduction; D010627:Phenethylamines / Q000378:metabolism*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014439:Tyramine / Q000378:metabolism
D001679:Biogenic Amines; D010627:Phenethylamines; D012701:Serotonin; D008995:Monoamine Oxidase; D004298:Dopamine; D014439:Tyramine